Skip to content

The success rate of different anesthesia protocols in mandibular posterior teeth

Comparison of the success rate of different anesthesia protocols in mandibular first molars with symptomatic irreversible pulpitis using prilocain local anesthesia : A randomized control clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20101108005141N7
Enrollment
128
Registered
2018-04-04
Start date
2018-01-09
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic irreversible pulpitis. Pulpitis

Interventions

Intervention 1: Intervention group1:IANB(Inferior alveolar nerve block) standard injection using prilocaine 3% solution (Prilocaine, Felypressin 0.03 IU/Darou Pakhsh,Iran ) will be done . After 15

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Subjects 18-65 years of age No sensitivity to anesthetic agent No facial parasthesia Do not use of any narcotic drug 6 hours before treatment Patient not to be pregnancy No history of truma Absence of pathologic pockets during probing Patient with mandibular first molar with symptomatic irriversible pulpitis Normal view of teeth in periapical region

Exclusion criteria

Exclusion criteria: Any patients have not inclusion criteria Any illness that is unable to fill the informed consent form Absence of vital pulp tissue in access cavity

Design outcomes

Primary

MeasureTime frame
The amount of pain. Timepoint: During access cavity preparation and entrance in to the pulp chamber and the root canal. Method of measurement: Using Visual Analog Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahriar Shahi

Dental and Periodontal Research Center

sshahriar32@gmail.com+98 41 3335 5965

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026